J&J Enters LAA Closure Market In Earnest With Coherex Buy

Johnson & Johnson's Biosense Webster unit already is the exclusive distributor of Coherex Medical Inc.'s WaveCrest left atrial appendage occlusion system outside of the US, but the heart-rhythm device business now says it is acquiring the Coherex outright, expanding its commitment to the LAA closure space for reducing stroke in atrial fibrillation patients.